Antiviral activity of n-substituted 5-(Phenylamino) uracil derivatives against chikungunya virus

• Main Author: Noor Farah Binti Omar Ahmad (Author)
• Format: Thesis
• Published: Sungai Buloh, Selangor Universiti Teknologi MARA. Faculty of Medicine 2018
• Subjects: Aniline Compounds > adverse effects; Antiviral Agents > adverse effects; Chikungunya virus
• Online Access: Click Here to View Status and Holdings.
• Item Description: UiTM Digitized
• Physical Description: xx, 111 pages illustrations, charts (some colour) 30 cm 1 computer optical disc (4 ¾ in.)
• Format: System requirements for CD-ROM: Intel Pentium II or faster processor with 450 MHz (or equivalent), browser Internet Explorer 5.5 or higher (6.0 or higher recommended), Firefox 1.0.2 or higher, Acrobat
• Bibliography: Includes bibliographical references (page 94-108)

Chikungunya virus (CHIKV), is an arthropod-borne disease that causes Chikungunya fever. Currently, there is no available drug or vaccine to treat the infected CHIKV patients. Based on literature, novel N-substituted 5-(phenylamino)uracil derivatives exhibit inhibitory effects against HIV and Hepatitis C virus but not yet been tested on CHIKV. The half maximal cytotoxic concentration (CCs) of six 5-substituted (phenylamino) uracil and five 2,4-dioxo-3,4-dihydropyrimidine acetic acid compounds were at 200 µM and 800 μM respectively. Two compounds (Z214 and Z364) exhibited the best antiviral activity at concentration of 50 µM and 100 μM. Time-addition assay revealed that the inhibition was most efficient when Z214 (50 uM) and Z364 (100 μM) were added at 4 hour of post-infection (hpi) and at 6 hpi. This suggests that, these compounds have inhibitory effect as anti-CHIKV inhibitors at post-entry step of CHIKV replication cycle. Prophylactic treatment showed a decrease in number of CHIKV plaques when Z214 (50 μM) and 2364 (100 μM) were added 5 hours before infection by 100% and 71% ± 7.01 respectively. Z214 and 2354 exhibited a significant effect against CHIKV attachment and adsorption to the Vero cells at all tested concentrations (1.56 µM to 100 μM) as compared to the virus control. Both compounds exhibited inhibition against CHIKV internalization when the compounds (at all tested concentration ranging from 1.56 µM to 100 µM) were added during virus internalization. In conclusion, these compounds under novel N substituted 5-(phenylamino)uracil derivatives exhibited promising antiviral activity for Chikungunya virus and it could be further studied